Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-21-002863
Filing Date
2021-02-08
Accepted
2021-02-08 08:44:27
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 23361
2 ex3-1.htm EX-3.1 112233
3 ex99-1.htm EX-99.1 178557
4 ex99-2.htm EX-99.2 371216
5 ex99-3.htm EX-99.3 133312
6 ex99-4.htm EX-99.4 357312
7 ex99-5.htm EX-99.5 110834
8 ex99-2_001.jpg GRAPHIC 11032
9 ex99-5_001.jpg GRAPHIC 3790
10 ex99-5_002.jpg GRAPHIC 13240
11 ex99-5_003.jpg GRAPHIC 12878
  Complete submission text file 0001493152-21-002863.txt   3303043

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE bfra-20200630.xml EX-101.INS 290891
13 XBRL SCHEMA FILE bfra-20200630.xsd EX-101.SCH 85953
14 XBRL CALCULATION FILE bfra-20200630_cal.xml EX-101.CAL 56260
15 XBRL DEFINITION FILE bfra-20200630_def.xml EX-101.DEF 78240
16 XBRL LABEL FILE bfra-20200630_lab.xml EX-101.LAB 355252
17 XBRL PRESENTATION FILE bfra-20200630_pre.xml EX-101.PRE 158976
Mailing Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377
Business Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377 011 49 214 876 00
Biofrontera AG (Filer) CIK: 0001712641 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38396 | Film No.: 21598690
SIC: 2834 Pharmaceutical Preparations